US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell lymphoma after one prior therapy Read more
Zydus Lifesciences receives final approval from US FDA for Adapalene and Benzoyl Peroxide Topical Gel Read more
US FDA approves Roche’s Evrysdi for use in babies under two months with Spinal Muscular Atrophy Read more
US FDA approves Novartis Kymriah CAR-T cell therapy for adult patients with relapsed or refractory Follicular Lymphoma Read more